New approaches to the prevention of childhood atopic dermatitis
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
There has been a steep rise in the burden of atopic dermatitis (AD), and up to 20% of children in developed countries now suffer of the disease. At present, treatment at best achieves symptom control rather than cure, and there is a strong need to identify new methods of disease prevention. While earlier approaches focused on allergen avoidance strategies, there has been a clear shift towards attempts to induce tolerance and enhancement of skin barrier function, as skin barrier breakdown plays an important role in AD development. This article reviews the latest developments in the prevention of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New insights into the epidemiology of childhood atopic dermatitis
Flohr, C., & Mann, J. (2014) · Allergy · doi:10.1111/all.12270 · Cited by 499 · cited 6×
“The role of the microflora (or microbiota) of the gut in the development of AD has recently been subject of much investigation, and there is mounting evidence to suggest that children who develop AD have a reduced diversity in the gut microbiota (15).”
BackgroundSelf-citationLEWIS-JONES, S. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01047.x · Cited by 478
Zutavern, A., Brockow, I., Schaaf, B., von Berg, A., Diez, U., Borte, M., Kraemer, U., Herbarth, O., Behrendt, H., Wichmann, H.-E., et al. (2008) · Pediatrics · doi:10.1542/peds.2006-3553 · Cited by 262
Schmitt, J., von Kobyletzki, L., Svensson, Å., & Apfelbacher, C. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10030.x · Cited by 257 · cited 1×
“However, proactive (‘weekend’) therapy is able to effectively reduce the frequency of disease flares and consequently leads to less use of topical anti-inflammatory medication (68).”
BackgroundFlohr, C., England, K., Radulovic, S., McLean, W. H. I., Campbell, L. E., Barker, J., Perkin, M., & Lack, G. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10068.x · Cited by 251
Self-citationDoes “autoreactivity” play a role in atopic dermatitis?
Tang, T. S., Bieber, T., & Williams, H. C. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.02.002 · Cited by 146 · cited 1×
“Given the emerging role of skin inflammation in skin barrier breakdown and the aetiology of food and respiratory allergies (70), more effective AD flare and disease control might even help to prevent some children from following the so-called atopic march (71).”
BackgroundAtopic dermatitis: a candidate for disease‐modifying strategy
Bieber, T., Cork, M., & Reitamo, S. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02845.x · Cited by 131 · cited 1×
“This, in turn, could have a positive effect on AD chronicity and severity, but intervention studies are needed to prove this concept (72).”
BackgroundEpidermal Barrier in Atopic Dermatitis
Kim, B. E., & Leung, D. Y. (2012) · Allergy, Asthma and Immunology Research · doi:10.4168/aair.2012.4.1.12 · Cited by 114
Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis
Elias, P. M., & Wakefield, J. S. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8231-1 · Cited by 103
Cited by
Atopic Dermatitis: Global Epidemiology and Risk Factors
Nutten, S. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000370220 · Cited by 3,055
Staphylococcus aureus and Atopic Dermatitis: A Complex and Evolving Relationship
Geoghegan, J. A., Irvine, A. D., & Foster, T. J. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2017.11.008 · Cited by 511
Kim, K. E., Cho, D., & Park, H. J. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.03.039 · Cited by 455
The role of filaggrin in atopic dermatitis and allergic disease
Drislane, C., & Irvine, A. D. (2020) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2019.10.008 · Cited by 311
Atopic dermatitis: the skin barrier and beyond
Tsakok, T., Woolf, R., Smith, C. H., Weidinger, S., & Flohr, C. (2019) · British Journal of Dermatology · doi:10.1111/bjd.16934 · Cited by 287
Self-citationSkjerven, H. O., Rehbinder, E. M., Vettukattil, R., LeBlanc, M., Granum, B., Haugen, G., Hedlin, G., Landrø, L., Marsland, B. J., Rudi, K., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32983-6 · Cited by 234
The exposome in atopic dermatitis
Stefanovic, N., Flohr, C., & Irvine, A. D. (2020) · Allergy · doi:10.1111/all.13946 · Cited by 181
Self-citationRelationship between atopic dermatitis and food allergy
Domínguez, O., Plaza, A. M., & Alvaro, M. (2020) · Current Pediatric Reviews · doi:10.2174/1573396315666191111122436 · Cited by 37
Metadata
- Authors
- Flohr, C., & Mann, J.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2013-12-26
- Volume
- 69
- Issue
- 1
- Pages
- 56-61
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W1983256659
- Cited by
- 48
- References
- 9
- FWCI
- 7.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.